Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials.

Autor: King-Kallimanis BL; LUNGevity Foundation, Bethesda, MD, USA. Electronic address: bking-kallimanis@lungevity.org., Calvert M; Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, England, UK; Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, England, UK; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, England, UK; NIHR Applied Research Collaboration (ARC) West Midlands, University of Birmingham, Birmingham, England, UK; Health Data Research UK, London, England, UK; NIHR Birmingham-Oxford Blood and Transplant Research Unit in Precision Transplant and Cellular Therapeutics, University of Birmingham, UK., Cella D; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Cocks K; Adelphi Values, Cheshire, England, UK., Coens C; Quality of Life Department, EORTC HQ, Brussels, Belgium., Fairclough D; Colorado School of Public Health, Aurora, CO, USA., Howie L; Pardee Cancer Center, Hendersonville, NC, USA., Jonsson P; Data and Analytics, National Institute for Health and Care Excellence (NICE), Manchester, UK., Mahendraratnam N; Aetion, Inc New York, NY, USA., Maues J; Patient Advocate/GRASP, Baltimore, MA, USA., Sarac S; Member of CHMP (EMA), Danish Medicines Agency, Copenhagen, Denmark., Shaw J; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Stigger N; Patient Advocate, Chicago, IL, USA., Trask P; Genentech, Inc, South San Francisco, CA, USA., Wieseler B; Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2023 Oct; Vol. 26 (10), pp. 1543-1548. Date of Electronic Publication: 2023 Jul 06.

Letter to the Editor regarding Wieseler B.: Beyond Journal Publication

Publikováno v: Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen; August 2017, Vol. 125 Issue: 1 p89-89, 1p

Replacing RCTs with real world data for regulatory decision making: a self-fulfilling prophecy?

Autor: Wieseler B; Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany beate.wieseler@iqwig.de., Neyt M; Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium., Kaiser T; Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany., Hulstaert F; Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium., Windeler J; Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany.

Publikováno v: BMJ (Clinical research ed.) [BMJ] 2023 Mar 02; Vol. 380, pp. e073100. Date of Electronic Publication: 2023 Mar 02.

From publication bias to lost in information: why we need a central public portal for clinical trial data.

Autor: Wieseler B; Institute for Quality and Efficiency in Health Care, Köln, Germany beate.wieseler@iqwig.de., McGauran N; Institute for Quality and Efficiency in Health Care, Köln, Germany.

Publikováno v: BMJ evidence-based medicine [BMJ Evid Based Med] 2022 Apr; Vol. 27 (2), pp. 74-76. Date of Electronic Publication: 2020 Dec 10.

Centralised Full Access to Clinical Study Data Can Support Unbiased Guideline Development, Continuing Medical Education, and Patient Information.

Autor: McGauran N; Communications Department, Institute for Quality and Efficiency in Health Care (IQWIG), Cologne, Germany., Wieseler B; Drug Assessment Department, Institute for Quality and Efficiency in Health Care (IQWIG), Cologne, Germany.

Publikováno v: Journal of European CME [J Eur CME] 2021 Nov 22; Vol. 10 (1), pp. 1989172. Date of Electronic Publication: 2021 Nov 22 (Print Publication: 2021).